phase readout

NCT03173092: A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)

ACTIVE_NOT_RECRUITINGupdated 2mo ago

community read0 votes

Sponsor: Takeda. Phase: PHASE4. Conditions: Multiple Myeloma

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 3h ago

Found something off?